Sana Biotechnology Inc (SANA)

$4.12 -0.24 (-5.50%)
Market Cap 1.00B
Revenue (ttm) 0.00
Net Income (ttm) -266.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,454,966
Avg Vol 5,296,188
Day's Range N/A - N/A
Shares Out 225.48M
Stochastic %K 17%
Beta 1.86
Analysts Strong Sell
Price Target $9.33

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline consist of UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
Poshfox
Poshfox Jul. 31 at 6:49 PM
$SANA this is starting to feel/look like a pre offering short. Buyers pre shorting their shares as a hedge. May be wrong, but hopefully this is one of the rare ones that goes up after relieving $$ pressure.
0 · Reply
cta7978
cta7978 Jul. 31 at 6:10 PM
$SANA Quite a dump, I guess shorty piling back on due to no rate cuts?
0 · Reply
CelestialIronMan
CelestialIronMan Jul. 31 at 12:11 PM
$SANA 🫤 No and who cares? People would let one clown fcktard re-shape reality here too? No amount of penmanship can change the MRI and C-peptide data we already have. Which is exactly why this question is beyond moot.
0 · Reply
Poshfox
Poshfox Jul. 30 at 8:02 PM
$SANA Did shkrelli say smthg about Sana? Seeing ppl writing “sure as u were w/ Sana…?” theres a list of other tickers but sana is one. I went & looked & found a 50 min clip of nothing. Wondering if sana is getting lumped?
1 · Reply
bonhommetwits
bonhommetwits Jul. 30 at 2:25 PM
$SANA I am in for the long haul. With that said, look at the short interest on this. 6 days to cover.... 27% plus.... Enough said!
1 · Reply
SanaMontana
SanaMontana Jul. 30 at 2:18 PM
$SANA I’m no Jerry Malone but I do have my largest position of any single stock I’ve ever owned here and holding for the cure!
0 · Reply
JerryMalone32
JerryMalone32 Jul. 30 at 1:53 PM
$SANA I added 2,000 shares at $4.47 at the open this morning. Now own 240,000 shares (at $4.53 avg. cost). Hopefully, we get something good in the way of news before Thanksgiving.
1 · Reply
CelestialIronMan
CelestialIronMan Jul. 30 at 11:28 AM
$ATYR this is one of the best pieces of investment advice from a mental and behavioral standpoint I’ve ever read. Every new biotech investor should read this! $SANA tagged for my ppl over there!
0 · Reply
IMC69
IMC69 Jul. 29 at 7:54 PM
$SANA Tomorrow the fed chairman speaks so any announcement on rate cuts will most likely bring confidence back to this market .... On a side note, anyone looking for bottom fishing here's a 4-H Chart with a Fibonacci Retracement levels and a volume profile for better read. My SANA bags are full but there's always room for more:) Do your own diligence!
1 · Reply
Dr_Jan_Itor
Dr_Jan_Itor Jul. 29 at 7:31 PM
$SANA Not trying to bash at all here (I own the stock), but does anyone know how big the risk is for a capital injection?
2 · Reply
Latest News on SANA
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 10:05 AM EDT - 5 weeks ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Two Biotech Stocks Poised For Big Moves On Monday

Jun 23, 2025, 7:39 AM EDT - 5 weeks ago

Two Biotech Stocks Poised For Big Moves On Monday

LCTX

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 9, 2025, 4:05 PM EDT - 7 weeks ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Sana Biotechnology to Present at June 2025 Investor Conferences

May 28, 2025, 4:05 PM EDT - 2 months ago

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

May 19, 2025, 3:10 PM EDT - 2 months ago

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

May 19, 2025, 11:57 AM EDT - 2 months ago

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

May 14, 2025, 2:50 PM EDT - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 2 months ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

May 8, 2025, 5:45 AM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Apr 19, 2025, 8:10 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421

Mar 24, 2025, 11:45 PM EDT - 4 months ago

Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Mar 17, 2025, 4:05 PM EDT - 4 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Feb 24, 2025, 4:05 PM EST - 5 months ago

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 4:05 PM EST - 7 months ago

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success

Jan 8, 2025, 10:30 AM EST - 7 months ago

Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success

Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why

Jan 8, 2025, 9:27 AM EST - 7 months ago

Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why

This Biotech Stock Just Soared 240%. Why It Can Go Higher.

Jan 8, 2025, 7:25 AM EST - 7 months ago

This Biotech Stock Just Soared 240%. Why It Can Go Higher.

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jan 7, 2025, 4:05 PM EST - 7 months ago

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus

Dec 4, 2024, 3:36 PM EST - 8 months ago

Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus

Sana Biotechnology to Present at December 2024 Investor Conferences

Nov 25, 2024, 4:05 PM EST - 8 months ago

Sana Biotechnology to Present at December 2024 Investor Conferences

Sana Biotechnology: The Story Becomes Murkier

Nov 19, 2024, 5:31 PM EST - 9 months ago

Sana Biotechnology: The Story Becomes Murkier

Poshfox
Poshfox Jul. 31 at 6:49 PM
$SANA this is starting to feel/look like a pre offering short. Buyers pre shorting their shares as a hedge. May be wrong, but hopefully this is one of the rare ones that goes up after relieving $$ pressure.
0 · Reply
cta7978
cta7978 Jul. 31 at 6:10 PM
$SANA Quite a dump, I guess shorty piling back on due to no rate cuts?
0 · Reply
CelestialIronMan
CelestialIronMan Jul. 31 at 12:11 PM
$SANA 🫤 No and who cares? People would let one clown fcktard re-shape reality here too? No amount of penmanship can change the MRI and C-peptide data we already have. Which is exactly why this question is beyond moot.
0 · Reply
Poshfox
Poshfox Jul. 30 at 8:02 PM
$SANA Did shkrelli say smthg about Sana? Seeing ppl writing “sure as u were w/ Sana…?” theres a list of other tickers but sana is one. I went & looked & found a 50 min clip of nothing. Wondering if sana is getting lumped?
1 · Reply
bonhommetwits
bonhommetwits Jul. 30 at 2:25 PM
$SANA I am in for the long haul. With that said, look at the short interest on this. 6 days to cover.... 27% plus.... Enough said!
1 · Reply
SanaMontana
SanaMontana Jul. 30 at 2:18 PM
$SANA I’m no Jerry Malone but I do have my largest position of any single stock I’ve ever owned here and holding for the cure!
0 · Reply
JerryMalone32
JerryMalone32 Jul. 30 at 1:53 PM
$SANA I added 2,000 shares at $4.47 at the open this morning. Now own 240,000 shares (at $4.53 avg. cost). Hopefully, we get something good in the way of news before Thanksgiving.
1 · Reply
CelestialIronMan
CelestialIronMan Jul. 30 at 11:28 AM
$ATYR this is one of the best pieces of investment advice from a mental and behavioral standpoint I’ve ever read. Every new biotech investor should read this! $SANA tagged for my ppl over there!
0 · Reply
IMC69
IMC69 Jul. 29 at 7:54 PM
$SANA Tomorrow the fed chairman speaks so any announcement on rate cuts will most likely bring confidence back to this market .... On a side note, anyone looking for bottom fishing here's a 4-H Chart with a Fibonacci Retracement levels and a volume profile for better read. My SANA bags are full but there's always room for more:) Do your own diligence!
1 · Reply
Dr_Jan_Itor
Dr_Jan_Itor Jul. 29 at 7:31 PM
$SANA Not trying to bash at all here (I own the stock), but does anyone know how big the risk is for a capital injection?
2 · Reply
nrupen88
nrupen88 Jul. 29 at 6:27 PM
$SANA NVDA started 2% plus green and now negative. Markets selling for some reason in the afternoon
0 · Reply
GLPHOTOX
GLPHOTOX Jul. 29 at 5:46 PM
$SANA Any chart masters in here that can tell us where the support levels are ?
1 · Reply
SanaMontana
SanaMontana Jul. 29 at 5:10 PM
$SANA HODL IYKYK
0 · Reply
SanaMontana
SanaMontana Jul. 29 at 5:05 PM
$SANA I just hold through the highs and lows. It was bound to have a pullback after the past few months.
0 · Reply
Jessie_Livermore
Jessie_Livermore Jul. 29 at 4:40 PM
$SANA Same old story for every stock - accumulate, manipulate, distribute.
1 · Reply
CelestialIronMan
CelestialIronMan Jul. 29 at 4:30 PM
$SANA It's a trap, we're the least rate sensitive story on Wallstreet.
2 · Reply
Kjhhsskowow
Kjhhsskowow Jul. 29 at 3:46 PM
$SANA it goes to hell why?
0 · Reply
GLPHOTOX
GLPHOTOX Jul. 29 at 2:29 PM
$SANA did I miss some bad news ?
0 · Reply
GLPHOTOX
GLPHOTOX Jul. 29 at 2:03 PM
$SANA what’s the deal with the short raid? 😳😳
1 · Reply
JerryMalone32
JerryMalone32 Jul. 29 at 5:16 AM
$SANA Question for those much, much smarter than me. Is the scaling problem simply a function of a lot of capital and a lot of time. Or are there scientific challenges, too? What, specifically, would $VRTX lend to the task that could not be done by $SANA, itself?
1 · Reply
CelestialIronMan
CelestialIronMan Jul. 28 at 11:47 PM
$SANA where is the fkn down vote button?
0 · Reply
Esau815
Esau815 Jul. 28 at 11:45 PM
$SANA To my friend Kevin. News flash. Nobody is having tag days for Esau. I have been around the block a few times on pharma deals. TOP CASH is reserved for those companies with revenue producing drugs. Witness the $9.6B BPMC deal that just closed last week. $SANA has yet to prove that they can scale up that platform. That means that there is risk and any acquiring company will evaluate that risk in terms of providing cash. They simply aren't near the finish line and that distance to the finish line discounts the value of the company As I've said--now for the third time--I am rooting for $SANA like Spike Lee roots for the Knicks. I really want them to win. That said--with their limited cash and their distance to solving the scalability challenge--I hope that they will soon be a subsidiary of VRTX where it would be far more likely that their asset will be able to evolve into an FDA approved platform.
1 · Reply